Skip to content

Clinical trials

Obesity trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: Hungary Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20081
20091
20111
20173
20182
20213
20223
20238
20242
20259
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting12
Active, not recruiting6
Terminated6
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S15
Amgen7
Eli Lilly and Company6
Sanofi4
Boehringer Ingelheim3
AstraZeneca2
Novartis Pharmaceuticals2
Semmelweis University2
Gelesis, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity44
Overweight23
Diabetes Mellitus, Type 213
Diabetes Mellitus4
Sleep Apnea, Obstructive3
Cardiovascular Diseases2
Heart Failure2
Hypertension2
Insulin Resistance2
Renal Insufficiency, Chronic2

Trials

Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.